Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.64 billion. The enterprise value is $1.64 billion.
Market Cap | 1.64B |
Enterprise Value | 1.64B |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, before market open.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 46.76 million shares outstanding. The number of shares has increased by 2.31% in one year.
Current Share Class | 46.76M |
Shares Outstanding | 46.76M |
Shares Change (YoY) | +2.31% |
Shares Change (QoQ) | +0.92% |
Owned by Insiders (%) | 2.61% |
Owned by Institutions (%) | 102.44% |
Float | 45.52M |
Valuation Ratios
The trailing PE ratio is 130.93 and the forward PE ratio is 19.82. Omnicell's PEG ratio is 4.10.
PE Ratio | 130.93 |
Forward PE | 19.82 |
PS Ratio | 1.46 |
Forward PS | 1.41 |
PB Ratio | 1.32 |
P/TBV Ratio | 6.22 |
P/FCF Ratio | 10.77 |
P/OCF Ratio | 8.68 |
PEG Ratio | 4.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.16, with an EV/FCF ratio of 10.86.
EV / Earnings | 131.13 |
EV / Sales | 1.48 |
EV / EBITDA | 26.16 |
EV / EBIT | 299.30 |
EV / FCF | 10.86 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.31.
Current Ratio | 1.37 |
Quick Ratio | 1.07 |
Debt / Equity | 0.31 |
Debt / EBITDA | 5.23 |
Debt / FCF | 2.53 |
Interest Coverage | 1.04 |
Financial Efficiency
Return on equity (ROE) is 1.03% and return on invested capital (ROIC) is 0.20%.
Return on Equity (ROE) | 1.03% |
Return on Assets (ROA) | 0.16% |
Return on Invested Capital (ROIC) | 0.20% |
Return on Capital Employed (ROCE) | 0.36% |
Revenue Per Employee | $303,062 |
Profits Per Employee | $3,414 |
Employee Count | 3,670 |
Asset Turnover | 0.51 |
Inventory Turnover | 6.41 |
Taxes
In the past 12 months, Omnicell has paid $13.06 million in taxes.
Income Tax | 13.06M |
Effective Tax Rate | 51.04% |
Stock Price Statistics
The stock price has increased by +19.73% in the last 52 weeks. The beta is 0.85, so Omnicell's price volatility has been lower than the market average.
Beta (5Y) | 0.85 |
52-Week Price Change | +19.73% |
50-Day Moving Average | 39.06 |
200-Day Moving Average | 39.94 |
Relative Strength Index (RSI) | 43.35 |
Average Volume (20 Days) | 670,504 |
Short Selling Information
The latest short interest is 1.83 million, so 3.91% of the outstanding shares have been sold short.
Short Interest | 1.83M |
Short Previous Month | 1.77M |
Short % of Shares Out | 3.91% |
Short % of Float | 4.01% |
Short Ratio (days to cover) | 3.13 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.11 billion and earned $12.53 million in profits. Earnings per share was $0.27.
Revenue | 1.11B |
Gross Profit | 475.51M |
Operating Income | 5.49M |
Pretax Income | -20.77M |
Net Income | 12.53M |
EBITDA | 62.82M |
EBIT | 5.49M |
Earnings Per Share (EPS) | $0.27 |
Balance Sheet
The company has $369.20 million in cash and $382.55 million in debt, giving a net cash position of -$13.35 million or -$0.29 per share.
Cash & Cash Equivalents | 369.20M |
Total Debt | 382.55M |
Net Cash | -13.35M |
Net Cash Per Share | -$0.29 |
Equity (Book Value) | 1.24B |
Book Value Per Share | 26.81 |
Working Capital | 219.82M |
Cash Flow
In the last 12 months, operating cash flow was $187.72 million and capital expenditures -$36.46 million, giving a free cash flow of $151.26 million.
Operating Cash Flow | 187.72M |
Capital Expenditures | -36.46M |
Free Cash Flow | 151.26M |
FCF Per Share | $3.23 |
Margins
Gross margin is 42.75%, with operating and profit margins of 0.49% and 1.13%.
Gross Margin | 42.75% |
Operating Margin | 0.49% |
Pretax Margin | 2.30% |
Profit Margin | 1.13% |
EBITDA Margin | 5.65% |
EBIT Margin | 0.49% |
FCF Margin | 13.60% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.31% |
Shareholder Yield | -2.31% |
Earnings Yield | 0.77% |
FCF Yield | 9.28% |
Analyst Forecast
The average price target for Omnicell is $51.00, which is 45.67% higher than the current price. The consensus rating is "Buy".
Price Target | $51.00 |
Price Target Difference | 45.67% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 15.20% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.03 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.03 |
Piotroski F-Score | 5 |